GBC provides a comprehensive IVD ELISA solution for detecting HBsAg, HCV, and HIV Ag/Ab designed specifically for blood bank and large-scale screening settings. All reagents are CE marked and licensed by TFDA, ensuring regulatory compliance and reliability.

The platform integrates with the Dynex DSX automated ELISA analyzer, capable of handling both single-strip tests and full-plate runs, enabling flexible throughput. Modularity and automation reduce manual steps and operator variability, delivering consistent and predictable results.

With decades of applied experience in ELISA reagents and diagnostics, GBC ensures high accuracy, lot-to-lot consistency, and support for scalable operations including blood donor screening, infectious disease surveillance, and transfusion safety.